Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS

Polycystic ovary syndrome (PCOS) is characterized by elevated androgen production and subclinical changes in cardiovascular and metabolic risk markers. Total cholesterol, high-density lipoprotein (HDL) cholesterol, fasting glucose, and fasting insulin appear to increase specifically in PCOS compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Cignarella, Andrea, Mioni, Roberto, Sabbadin, Chiara, Dassie, Francesca, Parolin, Matteo, Vettor, Roberto, Barbot, Mattia, Scaroni, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765466/
https://www.ncbi.nlm.nih.gov/pubmed/33334002
http://dx.doi.org/10.3390/ijms21249554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765466/
https://www.ncbi.nlm.nih.gov/pubmed/33334002
http://dx.doi.org/10.3390/ijms21249554

Ejemplares similares